Sung Soo Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sung Soo Kim has a total of 84 co-authors. Here are the top co-authors by number of shared publications:
- Da Hyun Jung
Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
2 shared publications - Dae Young Cheung
Department of Internal Medicine, Yeouido St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
2 shared publications Hyun Ho Choi
Uijeongbu St. Mary’s Hospital, The Catholic University of Korea
2 shared publicationsHyung Keun Kim
Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea
2 shared publicationsIn Sik Chung
Department of Internal Medicine, Uijongbu St Mary Hospital, The Catholic University of Korea, Uijongbu 480-717, Korea
2 shared publications- Jie-Hyun Kim
Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
2 shared publications
Latest Publications
- Open Access
- 16 January 2026
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 20 (4) , 562-574
Randomized, Double-Blind, Active-Controlled, Parallel, Phase 3 Clinical Trial for Evaluating the Efficacy and Safety of Zastaprazan in Patients with Gastric Ulcers
Kyung Sik Park, Hyun-Soo Kim, Jung-Hwan Oh, Woo Chul Chung, Suck Chei Choi, Si Hyung Lee, Tae Ho Kim, Dae Young Cheung, Gwang Ho Baik, Sun Moon Kim, Hang Lak Lee, Jeong Seop Moon, Cheol Woong Choi, Chongil Sohn, Kyoung Oh Kim, Byung-Wook Kim, Hye-Kyung Jung, Da Hyun Jung, Sung Soo Kim, Moo In Park, Ju Yup Lee, Gwang Ha Kim, Hee Seok Moon, Hoonjai Chun, Ki-Nam Shim, Woon Geon Shin, Chan Hyuk Park, Taeoh Kim, Sung Woo Jung, Hyunjin Kim, Sam Ryong Jee, Keemyung Lee, Yu Kyung Cho, Sung Chul Park, Jinwoong Cho, Chealwung Huh, Hyesoo Kwon, Jun Kim, John Kim, Jong-Jae Park. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl250334
- 16 January 2026
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 20 (4) , 562-574
Open AccessRandomized, Double-Blind, Active-Controlled, Parallel, Phase 3 Clinical Trial for Evaluating the Efficacy and Safety of Zastaprazan in Patients with Gastric Ulcers
Kyung Sik Park, Hyun-Soo Kim, Jung-Hwan Oh, Woo Chul Chung, Suck Chei Choi, Si Hyung Lee, Tae Ho Kim, Dae Young Cheung, Gwang Ho Baik, Sun Moon Kim, Hang Lak Lee, Jeong Seop Moon, Cheol Woong Choi, Chongil Sohn, Kyoung Oh Kim, Byung-Wook Kim, Hye-Kyung Jung, Da Hyun Jung, Sung Soo Kim, Moo In Park, Ju Yup Lee, Gwang Ha Kim, Hee Seok Moon, Hoonjai Chun, Ki-Nam Shim, Woon Geon Shin, Chan Hyuk Park, Taeoh Kim, Sung Woo Jung, Hyunjin Kim, Sam Ryong Jee, Keemyung Lee, Yu Kyung Cho, Sung Chul Park, Jinwoong Cho, Chealwung Huh, Hyesoo Kwon, Jun Kim, John Kim, Jong-Jae Park. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl250334
- 10 December 2024
- Published by Springer Nature
- p. 77-82
Empirical Therapy
- Open Access
- 30 May 2023
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 56 (3) , 325-332
Accuracy of administrative claim data for gastric adenoma after endoscopic resection
Background/Aims: Administrative databases provide valuable information for large-cohort studies. This study aimed to evaluate the diagnostic accuracy of an administrative database for resected gastric adenomas.Methods: Data of patients who underwent endoscopic resection for benign gastric lesions were collected from three hospitals. Gastric adenoma cases were identified in the hospital database using International Classification of Diseases (ICD) 10-codes. The non-adenoma group included patients without gastric adenoma codes. The diagnostic accuracy for gastric adenoma was analyzed based on the pathological reports of the resected specimen.Results: Among 5,095 endoscopic resections with codes for benign gastric lesions, 3,909 patients were included in the analysis. Among them, 2,831 and 1,078 patients were allocated to the adenoma and non-adenoma groups, respectively. Regarding the overall diagnosis of gastric adenoma with ICD-10 codes, the sensitivity, specificity, positive predictive value, and negative predictive value were 98.7%, 88.5%, 95.2%, and 96.8%, respectively. There were no significant differences in these parameters between the tertiary and secondary centers.Conclusions: Administrative codes of gastric adenoma, according to ICD-10 codes, showed good accuracy and can serve as a useful tool to study prognosis of these patients in real-world data studies in the future.
- 30 May 2023
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 56 (3) , 325-332
Open AccessAccuracy of administrative claim data for gastric adenoma after endoscopic resection
Background/Aims: Administrative databases provide valuable information for large-cohort studies. This study aimed to evaluate the diagnostic accuracy of an administrative database for resected gastric adenomas.Methods: Data of patients who underwent endoscopic resection for benign gastric lesions were collected from three hospitals. Gastric adenoma cases were identified in the hospital database using International Classification of Diseases (ICD) 10-codes. The non-adenoma group included patients without gastric adenoma codes. The diagnostic accuracy for gastric adenoma was analyzed based on the pathological reports of the resected specimen.Results: Among 5,095 endoscopic resections with codes for benign gastric lesions, 3,909 patients were included in the analysis. Among them, 2,831 and 1,078 patients were allocated to the adenoma and non-adenoma groups, respectively. Regarding the overall diagnosis of gastric adenoma with ICD-10 codes, the sensitivity, specificity, positive predictive value, and negative predictive value were 98.7%, 88.5%, 95.2%, and 96.8%, respectively. There were no significant differences in these parameters between the tertiary and secondary centers.Conclusions: Administrative codes of gastric adenoma, according to ICD-10 codes, showed good accuracy and can serve as a useful tool to study prognosis of these patients in real-world data studies in the future.
- Open Access
- 7 April 2022
- Published by Wiley in Journal of Oncology
- Vol. 2022, 1-9
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy for Rectal Cancer: Long-Term Results after Protocol-Based Treatment
Background. Volumetric modulated arc therapy (VMAT) with simultaneous integrated boost (SIB) is an advanced form of radiotherapy (RT) technology. The purpose of this study was to report long-term treatment outcomes in patients with locally advanced rectal cancer undergoing VMAT-SIB based concurrent chemoradiotherapy (CRT). Methods. Between January 2016 and January 2018, a total of 22 patients with operable stage II-III rectal adenocarcinoma were recruited for the pre-designed VMAT-SIB RT protocol. All patients underwent standard diagnostic and staging work-up. The RT target volumes included the following areas: PTV1=mesorectum that contained gross tumors and enlarged lymph node regions and PTV2=mesorectum and regional lymphatics from L4-5/S1 to 3-4cm below the tumor or levator ani muscle, excluding PTV1. The VMAT-SIB dose prescription was as follows: PTV1=52.5Gy/daily 2.1Gy/25 fractions, PTV2=45Gy/daily 1.8Gy/25 fractions. Results. The mean age of the study population was 64 (range, 18-84) years, and 15 (68.2) patients were male. Radical operation (total mesorectal excision) was performed by either low anterior resection, ultralow anterior resection, or abdominal perineal resection. All five (22.7) of the patients with confirmed increasing serum carcinoembryonic antigen (CEA) level at diagnosis showed normalization of serum CEA level after the planned treatment. Among 20 patients who underwent preoperative CRT and surgery, tumor down staging in T- and N-stages was achieved in 10 patients (50) and 13 patients (65), respectively, with 20 of ypT0/Tis. With a median follow-up of 54.2 (range, 22.6-61.1) months, the 5-year disease-free survival, overall survival, and local control rates were 64.6, 81.8, and 84.4, respectively. Five patients developed distant metastasis and one developed local recurrence as a first event. Two cases with anastomosis site leakage, three with adhesive ileus, and two with abscess formation were observed during postoperative periods. Conclusions. The current VMAT-SIB-based CRT protocol provided acceptable treatment and toxicity outcomes.
- 7 April 2022
- Published by Wiley in Journal of Oncology
- Vol. 2022, 1-9
Open AccessSimultaneous Integrated Boost Volumetric Modulated Arc Therapy for Rectal Cancer: Long-Term Results after Protocol-Based Treatment
Background. Volumetric modulated arc therapy (VMAT) with simultaneous integrated boost (SIB) is an advanced form of radiotherapy (RT) technology. The purpose of this study was to report long-term treatment outcomes in patients with locally advanced rectal cancer undergoing VMAT-SIB based concurrent chemoradiotherapy (CRT). Methods. Between January 2016 and January 2018, a total of 22 patients with operable stage II-III rectal adenocarcinoma were recruited for the pre-designed VMAT-SIB RT protocol. All patients underwent standard diagnostic and staging work-up. The RT target volumes included the following areas: PTV1=mesorectum that contained gross tumors and enlarged lymph node regions and PTV2=mesorectum and regional lymphatics from L4-5/S1 to 3-4cm below the tumor or levator ani muscle, excluding PTV1. The VMAT-SIB dose prescription was as follows: PTV1=52.5Gy/daily 2.1Gy/25 fractions, PTV2=45Gy/daily 1.8Gy/25 fractions. Results. The mean age of the study population was 64 (range, 18-84) years, and 15 (68.2) patients were male. Radical operation (total mesorectal excision) was performed by either low anterior resection, ultralow anterior resection, or abdominal perineal resection. All five (22.7) of the patients with confirmed increasing serum carcinoembryonic antigen (CEA) level at diagnosis showed normalization of serum CEA level after the planned treatment. Among 20 patients who underwent preoperative CRT and surgery, tumor down staging in T- and N-stages was achieved in 10 patients (50) and 13 patients (65), respectively, with 20 of ypT0/Tis. With a median follow-up of 54.2 (range, 22.6-61.1) months, the 5-year disease-free survival, overall survival, and local control rates were 64.6, 81.8, and 84.4, respectively. Five patients developed distant metastasis and one developed local recurrence as a first event. Two cases with anastomosis site leakage, three with adhesive ileus, and two with abscess formation were observed during postoperative periods. Conclusions. The current VMAT-SIB-based CRT protocol provided acceptable treatment and toxicity outcomes.
- Open Access
- 10 September 2020
- Published by Korean College of Helicobacter and Upper Gastrointestinal Research in The Korean Journal of Helicobacter and Upper Gastrointestinal Research
- Vol. 20 (3) , 233-236
Esophageal Carcinosarcoma in a Patient with Corrosive Esophagitis
Esophageal carcinosarcoma is a rare type of esophageal cancer characterized by both carcinomatous and sarcomatous components. Its endophytic growth tendency into the esophageal lumen leads to a higher curative resection rate. However, lymph node metastases in esophageal carcinosarcoma occur at a relatively early stage. We report a case of esophageal carcinosarcoma in a 52-year-old man who had dysphagia for 2 months and a history of ingestion of glacial acetic acid in adolescence. His endoscopy and chest CT results showed an 8.5-cm-sized ulcerative polypoid mass with multiple lymph node metastases in the mid-esophagus. Biopsy revealed an interweaving spindle cell proliferation with squamous dysplasia. Immunohistochemical staining showed positive expressions of vimentin and cytokeratin. Even though the patient received concomitant chemoradiotherapy with a stent insertion, he died 7 months after diagnosis. We herein present a case of corrosive esophagitis followed by esophageal carcinosarcoma that suggested the possibility of an association between the two diseases.
- 10 September 2020
- Published by Korean College of Helicobacter and Upper Gastrointestinal Research in The Korean Journal of Helicobacter and Upper Gastrointestinal Research
- Vol. 20 (3) , 233-236
Open AccessEsophageal Carcinosarcoma in a Patient with Corrosive Esophagitis
Esophageal carcinosarcoma is a rare type of esophageal cancer characterized by both carcinomatous and sarcomatous components. Its endophytic growth tendency into the esophageal lumen leads to a higher curative resection rate. However, lymph node metastases in esophageal carcinosarcoma occur at a relatively early stage. We report a case of esophageal carcinosarcoma in a 52-year-old man who had dysphagia for 2 months and a history of ingestion of glacial acetic acid in adolescence. His endoscopy and chest CT results showed an 8.5-cm-sized ulcerative polypoid mass with multiple lymph node metastases in the mid-esophagus. Biopsy revealed an interweaving spindle cell proliferation with squamous dysplasia. Immunohistochemical staining showed positive expressions of vimentin and cytokeratin. Even though the patient received concomitant chemoradiotherapy with a stent insertion, he died 7 months after diagnosis. We herein present a case of corrosive esophagitis followed by esophageal carcinosarcoma that suggested the possibility of an association between the two diseases.
- 1 March 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (4) , e8-e9
Asymptomatic Scattered Pigmented Flat Lesions in the Esophagus
- 1 March 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (4) , e8-e9
Asymptomatic Scattered Pigmented Flat Lesions in the Esophagus
- Open Access
- 1 January 2018
- Published by XMLink in Journal of Gastric Cancer
- Vol. 18 (1) , 82-89
Early Detection is Important to Reduce the Economic Burden of Gastric Cancer
Kim JH, et al. J Gastric Cancer. 2018 Mar;18(1):82-89. https://doi.org/10.5230/jgc.2018.18.e7
- 1 January 2018
- Published by XMLink in Journal of Gastric Cancer
- Vol. 18 (1) , 82-89
Open AccessEarly Detection is Important to Reduce the Economic Burden of Gastric Cancer
Kim JH, et al. J Gastric Cancer. 2018 Mar;18(1):82-89. https://doi.org/10.5230/jgc.2018.18.e7
- 1 December 2012
- Published by Elsevier in Cancer Letters
- Vol. 326 (1) , 96-104
Helicobacter pylori decreases p27 expression through the delta opioid receptor-mediated inhibition of histone acetylation within the p27 promoter
- 1 December 2012
- Published by Elsevier in Cancer Letters
- Vol. 326 (1) , 96-104
Helicobacter pylori decreases p27 expression through the delta opioid receptor-mediated inhibition of histone acetylation within the p27 promoter
- Open Access
- 1 January 2012
- Published by The Korean Society of Gastroenterology in The Korean Journal of Gastroenterology
- Vol. 60 (2) , 79-85
DNA Double Strand Breaks in Gastric Epithelium withHelicobacter pyloriInfection
Chang YJ, et al. Korean J Gastroenterol. 2012 Aug;60(2):79-85. https://doi.org/10.4166/kjg.2012.60.2.79
- 1 January 2012
- Published by The Korean Society of Gastroenterology in The Korean Journal of Gastroenterology
- Vol. 60 (2) , 79-85
Open AccessDNA Double Strand Breaks in Gastric Epithelium withHelicobacter pyloriInfection
Chang YJ, et al. Korean J Gastroenterol. 2012 Aug;60(2):79-85. https://doi.org/10.4166/kjg.2012.60.2.79
- Open Access
- 1 January 2012
- Published by Korean College of Helicobacter and Upper Gastrointestinal Research in The Korean Journal of Helicobacter and Upper Gastrointestinal Research
- Vol. 12 (2) , 67-70
Natural History and Follow-up Strategy of Barrett's Esophagus
- 1 January 2012
- Published by Korean College of Helicobacter and Upper Gastrointestinal Research in The Korean Journal of Helicobacter and Upper Gastrointestinal Research
- Vol. 12 (2) , 67-70
Open AccessNatural History and Follow-up Strategy of Barrett's Esophagus